135 related articles for article (PubMed ID: 37930732)
1. Potential Use of Extracellular Vesicles in the Treatment of Intervertebral Disc Degeneration.
Li QW; Guo RC; Wu ZM; Shen CL
Tissue Eng Part C Methods; 2024 Feb; 30(2):73-84. PubMed ID: 37930732
[TBL] [Abstract][Full Text] [Related]
2. [Advances in the role of extracellular vesicles in intervertebral disc degeneration].
Zhang H; Wei Y; Ma C; Li L; Tao Z; Ren Y
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2023 Feb; 37(2):208-214. PubMed ID: 36796818
[TBL] [Abstract][Full Text] [Related]
3. Regulating pyroptosis by mesenchymal stem cells and extracellular vesicles: A promising strategy to alleviate intervertebral disc degeneration.
Yang S; Zhang Y; Peng Q; Meng B; Wang J; Sun H; Chen L; Dai R; Zhang L
Biomed Pharmacother; 2024 Jan; 170():116001. PubMed ID: 38128182
[TBL] [Abstract][Full Text] [Related]
4. Extracellular vesicles derived from mesenchymal stem cells confer protection against intervertebral disc degeneration through a microRNA-217-dependent mechanism.
Hao Y; Zhu G; Yu L; Ren Z; Zhang P; Zhu J; Cao S
Osteoarthritis Cartilage; 2022 Nov; 30(11):1455-1467. PubMed ID: 36041665
[TBL] [Abstract][Full Text] [Related]
5. Induced pluripotent stem cell-derived mesenchymal stem cells deliver exogenous miR-105-5p via small extracellular vesicles to rejuvenate senescent nucleus pulposus cells and attenuate intervertebral disc degeneration.
Sun Y; Zhang W; Li X
Stem Cell Res Ther; 2021 May; 12(1):286. PubMed ID: 33985571
[TBL] [Abstract][Full Text] [Related]
6. Cartilage endplate stem cells inhibit intervertebral disc degeneration by releasing exosomes to nucleus pulposus cells to activate Akt/autophagy.
Luo L; Jian X; Sun H; Qin J; Wang Y; Zhang J; Shen Z; Yang D; Li C; Zhao P; Liu M; Tian Z; Zhou Y
Stem Cells; 2021 Apr; 39(4):467-481. PubMed ID: 33459443
[TBL] [Abstract][Full Text] [Related]
7. Ultrashort time-to-echo T2* and T2* relaxometry for evaluation of lumbar disc degeneration: a comparative study.
Wu LL; Liu LH; Rao SX; Wu PY; Zhou JJ
BMC Musculoskelet Disord; 2022 Jun; 23(1):524. PubMed ID: 35650645
[TBL] [Abstract][Full Text] [Related]
8. Pretreatment of nucleus pulposus mesenchymal stem cells with appropriate concentration of H
Zhang YY; Hu ZL; Qi YH; Li HY; Chang X; Gao XX; Liu CH; Li YY; Lou JH; Zhai Y; Li CQ
Stem Cell Res Ther; 2022 Jul; 13(1):340. PubMed ID: 35883157
[TBL] [Abstract][Full Text] [Related]
9. Assessment of changes in the micro-nano environment of intervertebral disc degeneration based on Pfirrmann grade.
Che YJ; Guo JB; Liang T; Chen X; Zhang W; Yang HL; Luo ZP
Spine J; 2019 Jul; 19(7):1242-1253. PubMed ID: 30710732
[TBL] [Abstract][Full Text] [Related]
10. Granulocyte-colony stimulating factor improves intervertebral disc degeneration in experimental adult male rats: A microscopic and radiological study.
Abdel Fattah IO; Nasr El-Din WA
Anat Rec (Hoboken); 2021 Apr; 304(4):787-802. PubMed ID: 33015986
[TBL] [Abstract][Full Text] [Related]
11. ISSLS PRIZE in Basic Science 2024: superiority of nucleus pulposus cell- versus mesenchymal stromal cell-derived extracellular vesicles in attenuating disc degeneration and alleviating pain.
Ambrosio L; Schol J; Ruiz-Fernandez C; Tamagawa S; Soma H; Tilotta V; Di Giacomo G; Cicione C; Nakayama S; Kamiya K; Papalia R; Sato M; Vadalà G; Watanabe M; Denaro V; Sakai D
Eur Spine J; 2024 May; 33(5):1713-1727. PubMed ID: 38416190
[TBL] [Abstract][Full Text] [Related]
12. Extracellular Vesicles as an Emerging Treatment Option for Intervertebral Disc Degeneration: Therapeutic Potential, Translational Pathways, and Regulatory Considerations.
DiStefano TJ; Vaso K; Danias G; Chionuma HN; Weiser JR; Iatridis JC
Adv Healthc Mater; 2022 Mar; 11(5):e2100596. PubMed ID: 34297485
[TBL] [Abstract][Full Text] [Related]
13. ROS-responsive magnesium-containing microspheres for antioxidative treatment of intervertebral disc degeneration.
Zhang T; Wang Y; Li R; Xin J; Zheng Z; Zhang X; Xiao C; Zhang S
Acta Biomater; 2023 Mar; 158():475-492. PubMed ID: 36640954
[TBL] [Abstract][Full Text] [Related]
14. Differential proteomic analysis of fetal and geriatric lumbar nucleus pulposus: immunoinflammation and age-related intervertebral disc degeneration.
Qiu C; Wu X; Bian J; Ma X; Zhang G; Guo Z; Wang Y; Ci Y; Wang Q; Xiang H; Chen B
BMC Musculoskelet Disord; 2020 Jun; 21(1):339. PubMed ID: 32487144
[TBL] [Abstract][Full Text] [Related]
15. Mesenchymal Stem Cell-Derived Exosomes and Intervertebral Disc Regeneration: Review.
Bhujel B; Shin HE; Choi DJ; Han I
Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35806304
[TBL] [Abstract][Full Text] [Related]
16. Vasorin-containing small extracellular vesicles retard intervertebral disc degeneration utilizing an injectable thermoresponsive delivery system.
Liao Z; Ke W; Liu H; Tong B; Wang K; Feng X; Hua W; Wang B; Song Y; Luo R; Liang H; Zhang W; Zhao K; Li S; Yang C
J Nanobiotechnology; 2022 Sep; 20(1):420. PubMed ID: 36123708
[TBL] [Abstract][Full Text] [Related]
17. Transplantation of gene-modified nucleus pulposus cells reverses rabbit intervertebral disc degeneration.
Liu Y; Li JM; Hu YG
Chin Med J (Engl); 2011 Aug; 124(16):2431-7. PubMed ID: 21933582
[TBL] [Abstract][Full Text] [Related]
18. TNF-α suppresses SHOX2 expression via NF-κB signaling pathway and promotes intervertebral disc degeneration and related pain in a rat model.
Ye F; Xu Y; Lin F; Zheng Z
J Orthop Res; 2021 Aug; 39(8):1745-1754. PubMed ID: 32816304
[TBL] [Abstract][Full Text] [Related]
19. Nanoscale Treatment of Intervertebral Disc Degeneration: Mesenchymal Stem Cell Exosome Transplantation.
Hu YC; Zhang XB; Lin MQ; Zhou HY; Cong MX; Chen XY; Zhang RH; Yu DC; Gao XD; Guo TW
Curr Stem Cell Res Ther; 2023; 18(2):163-173. PubMed ID: 35466881
[TBL] [Abstract][Full Text] [Related]
20. Molecular mechanism and therapeutic potential of HDAC9 in intervertebral disc degeneration.
Lei M; Lin H; Shi D; Hong P; Song H; Herman B; Liao Z; Yang C
Cell Mol Biol Lett; 2023 Dec; 28(1):104. PubMed ID: 38093179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
